Recurrent hypokalemic muscle weakness as an initial manifestation of wilson’ disease

Nephron

Volumn 73, Issue 3, 1996, Pages 477-479

  Chu, Chun Che ^a   Huang, Chin Chang ^a   Chit, Nai Shin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Hypokalemic muscle paralysis; Renal tubular acidosis; Wilson rsquo; s disease

Indexed keywords

ANTIUROLITHIASIS AGENT; CHELATING AGENT; PENICILLAMINE;

ADULT; ARM; ARTICLE; CASE REPORT; HUMAN; HYPOKALEMIA; KIDNEY TUBULE ACIDOSIS; MALE; MUSCLE WEAKNESS; PARALYSIS; PRIORITY JOURNAL; TREMOR; WILSON DISEASE;

ACIDOSIS, RENAL TUBULAR; ADOLESCENT; ATROPHY; BRAIN; CHELATING AGENTS; HEPATOLENTICULAR DEGENERATION; HUMANS; HYPOKALEMIA; MALE; MUSCLE WEAKNESS; PARALYSIS; PENICILLAMINE; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TREMOR;

EID: 0029987429     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189114     Document Type: Article

References (20)

1. Walshe JM: Wilson's disease; in Vinkcn PJ, Bruyn GW. Klawans HL (eds): Handbook of Clinical Neurology. Amsterdam, North Holland, 1976, vol 27, pp 379-414.
2. Strickland GT, Leu ML: Wilson's disease: Clinical and laboratory manifestation in 40 patients. Medicine 1975;54:1 13-137.
3. Chu NS, Hung TP: Geographic variations in Wilson's disease. J Neurol Sci 1993.,5:1-7.
4. Huang CC. Chu NS: Wilson's disease: Clinical analysis of 71 eases and comparison with previous Chinese series. J Formos Med Assoc 1992;91:502-507.
5. Stremmel W. Meyerrose KW. Niederau C, Hefter H, Kreuzpaintner G. Strohmever G: Wilson's disease: Clinical presentation, treatment. and survival. Ann Intern Med 1991:115: 720-726.
6. Xu H. Yang BX. Feng YK: Wilson's disease (hepatolenticular degeneration): Clinical analysis of 80 cases. Chin Med J 1981:94:673-678
7. Mcdalia A. Glabennan KI, Scheinberg IH: Neuropsychological impairment in Wilson's disease. Arch Neurol 1988;45:502-504.
8. Denny-Brown D: Hepatolenticular degeneration (Wilson's disease): Two different components. N Engl J Med 1964:270:1149-1156.
9. Pellet H, Gallard L, Monier D. Ruitton-Uglien-go H: Maladie de Wilson à début trompeur (hématurie puis syndrome d'hypertension porta-Ic). Pédiatrie 1965:20:472-473.
10. Bearn AG. Yu TF, Gutman AB: Renal function in Wilson's disease. J Clin Invest 1957;36: 1107-1114.
11. Reynolds ES, Tannen RL. Tyler HR: The renal lesion in Wilson's disease. Am J Med 1966:40: 518-527.
12. Fulop M. Stemlieb I. Scheinberg HI: Defective urinary acidification in Wilson's disease. Ann Intern Med 1968;68:770-777.
13. Leu ML. Strickland GT, Gutman RA: Renal function in Wilson's disease: Response to penicillamine therapy. Am J Med Sci 1970:260: 381-389.
14. Leu ML, Strickland GT: Renal tubular acidosis in Wilson's disease: Characteristics, mechanisms and implication. J Formos Med Assoc 1977:76:829-842.
15. Morris RC: Renal tubular acidosis: Mechanisms. classification and implication. N Engl J Med 1969:281:1405-1413.
16. Reynolds TB: Observation on the pathogenesis of renal tubular acidosis. Am.,1 Med !958;25: 503-515.
17. Christensen KS: Hypokalemic periodic paralysis secondary to renal tubular acidosis. Eur Neurol 1985:24:303-305.
18. Chu NS: Sensory evoked potentials in Wilson's disease. Brain 1986;109:491-507.
19. Sebastian A. McSherr YE. Morris RC: On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA). J Clin Invest 1971;50: 231-243.
20. Walshe JM: Effect of penicillamine on failure of renal acidification in Wilson's disease. Lancet 1968, 10:775-778.